Variant report

Variant	esv3692888
Chromosome Location	chr6:15675641-15694811
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:62)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:62 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:15672759..15682190-chr6:16128127..16132961,11	K562	blood:
2	chr6:15676839..15679833-chr6:16153654..16155926,2	K562	blood:
3	chr6:15680559..15683188-chr6:16129427..16132579,3	K562	blood:
4	chr6:15691382..15692187-chr6:16036682..16037471,3	MCF-7	breast:
5	chr6:15691113..15692695-chr6:16128540..16129716,25	MCF-7	breast:
6	chr6:15691598..15692189-chr6:15752757..15753288,2	MCF-7	breast:
7	chr6:15681708..15684305-chr6:15689801..15691675,2	K562	blood:
8	chr6:15690304..15694051-chr6:16129108..16131986,7	K562	blood:
9	chr6:15691141..15692187-chr6:16128576..16130145,22	MCF-7	breast:
10	chr6:15691679..15692211-chr6:15736266..15736989,2	K562	blood:
11	chr6:15684844..15687441-chr6:15880155..15881679,2	K562	blood:
12	chr6:15689750..15690620-chr6:16183530..16184123,2	MCF-7	breast:
13	chr6:15683311..15685899-chr6:16128191..16130449,3	K562	blood:
14	chr6:15628080..15630749-chr6:15690393..15693220,2	K562	blood:
15	chr6:15678420..15680634-chr6:15684808..15686738,2	K562	blood:
16	chr6:15678826..15681687-chr6:16136285..16138589,3	K562	blood:
17	chr6:15681708..15684305-chr6:15689801..15691675,2	K562	blood:
18	chr6:15691584..15692147-chr6:16171307..16172061,2	MCF-7	breast:
19	chr6:15691190..15692210-chr6:16168870..16169806,7	K562	blood:
20	chr6:15692594..15695303-chr6:15695960..15699366,3	K562	blood:
21	chr6:15689083..15690999-chr6:16131882..16134165,2	K562	blood:
22	chr6:15682033..15684824-chr6:15685357..15687470,3	MCF-7	breast:
23	chr6:15682633..15685781-chr6:15685826..15688802,3	K562	blood:
24	chr6:15686130..15687986-chr6:16130553..16132331,2	MCF-7	breast:
25	chr6:15244123..15245961-chr6:15691500..15694136,2	K562	blood:
26	chr6:15691034..15692122-chr6:16128597..16129547,5	K562	blood:
27	chr6:15691223..15691812-chr6:15803377..15804019,2	K562	blood:
28	chr6:15687375..15689354-chr6:15694199..15696327,2	MCF-7	breast:
29	chr6:15674092..15676465-chr6:16128146..16130347,2	MCF-7	breast:
30	chr6:15682633..15685781-chr6:15685826..15688802,3	K562	blood:
31	chr6:15661124..15663645-chr6:15690658..15693451,3	K562	blood:
32	chr6:15676527..15678703-chr6:16128031..16129735,2	MCF-7	breast:
33	chr6:15660394..15662870-chr6:15679792..15681475,2	K562	blood:
34	chr6:15686242..15688880-chr6:15691006..15692946,2	K562	blood:
35	chr6:15676701..15679445-chr6:16128067..16130744,3	K562	blood:
36	chr6:15690815..15692594-chr6:16152230..16153735,2	K562	blood:
37	chr6:15682033..15684824-chr6:15685357..15687470,3	MCF-7	breast:
38	chr6:15690838..15692168-chr6:16205606..16207465,12	MCF-7	breast:
39	chr6:15691207..15692253-chr6:16128861..16130251,7	MCF-7	breast:
40	chr6:15688875..15695962-chr6:16127988..16134034,16	MCF-7	breast:
41	chr6:15687375..15689354-chr6:15694199..15696327,2	MCF-7	breast:
42	chr6:15689774..15693088-chr6:16205829..16209132,3	K562	blood:
43	chr6:15690698..15692334-chr6:16182695..16185259,24	MCF-7	breast:
44	chr6:15678420..15680634-chr6:15684808..15686738,2	K562	blood:
45	chr6:15690946..15692172-chr6:16206408..16207438,18	K562	blood:
46	chr6:15690395..15693320-chr6:16127608..16130843,10	MCF-7	breast:
47	chr6:15670461..15672032-chr6:15680372..15682046,2	K562	blood:
48	chr6:15686282..15689020-chr6:16128019..16129871,2	K562	blood:
49	chr6:15691300..15692107-chr6:16168761..16169885,4	MCF-7	breast:
50	chr6:15687288..15693257-chr6:16127517..16131016,8	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DTNBP1-1	chr6:15682235-15682336	XLOC_005620

No data

Variant related genes	Relation type
ENSG00000047579	chromatin interactions
ENSG00000216364	chromatin interactions
ENSG00000271888	chromatin interactions
ENSG00000007944	chromatin interactions

Extended variants
information (count: 759 )
Associated
traits (count: 109 )

Variant overlapped rSNPs/rCNVs (count:759 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7755766	chr6:15675641-15675642	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs578157732	chr6:15675662-15675663	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs34241883	chr6:15675677-15675678	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs146756587	chr6:15675684-15675685	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs140325021	chr6:15675693-15675694	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs76450606	chr6:15675702-15675703	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs542652608	chr6:15675739-15675740	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs145466203	chr6:15675758-15675759	Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs138858555	chr6:15675805-15675806	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs540046461	chr6:15675806-15675807	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs183706668	chr6:15675833-15675834	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs545220024	chr6:15675851-15675852	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs187955301	chr6:15675855-15675856	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs527395189	chr6:15675870-15675871	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs547426390	chr6:15675906-15675907	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs528203830	chr6:15675951-15675952	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs560819964	chr6:15675963-15675964	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs529738086	chr6:15675967-15675968	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs549498076	chr6:15676003-15676004	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs191199689	chr6:15676014-15676015	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs184117309	chr6:15676034-15676035	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs35569988	chr6:15676038-15676039	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs74874076	chr6:15676039-15676040	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs529154780	chr6:15676113-15676114	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs565836396	chr6:15676149-15676150	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs150401672	chr6:15676160-15676161	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs188514775	chr6:15676177-15676178	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs534038194	chr6:15676223-15676224	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs116584785	chr6:15676256-15676257	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs138173605	chr6:15676271-15676272	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs562837834	chr6:15676294-15676295	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs533157012	chr6:15676316-15676317	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs149565451	chr6:15676323-15676324	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs192297116	chr6:15676325-15676326	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs576345467	chr6:15676373-15676374	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs372515411	chr6:15676376-15676377	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs114335314	chr6:15676392-15676393	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs147313629	chr6:15676426-15676427	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs566849539	chr6:15676454-15676455	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs572648169	chr6:15676471-15676472	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs17407828	chr6:15676477-15676478	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs549123910	chr6:15676517-15676518	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs377071710	chr6:15676556-15676557	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs529730931	chr6:15676579-15676580	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs567520636	chr6:15676593-15676594	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs543461395	chr6:15676606-15676607	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs563237948	chr6:15676630-15676631	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs370098244	chr6:15676637-15676638	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs551241105	chr6:15676700-15676701	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs7761222	chr6:15676707-15676708	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:109)

Disease	PMID	Source
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian cancer	21720365	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
abnormal development	18461090	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21785460	CNVD
Bladder cancer	16790693	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17142309	CNVD
Urothelial cell carcinoma	18451213	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Ovarian cancer	20844748	CNVD
Developmental delay	19490664	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:282 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:15672800-15677200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr6:15673200-15677400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr6:15673800-15676400	Enhancers	Fetal Muscle Leg	muscle
4	chr6:15674000-15677000	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr6:15674400-15676600	Enhancers	Psoas Muscle	Psoas
6	chr6:15674600-15676400	Enhancers	Primary hematopoietic stem cells short term culture	blood
7	chr6:15674600-15676600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr6:15674800-15675800	Enhancers	iPS-20b Cell Line	embryonic stem cell
9	chr6:15674800-15676200	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr6:15674800-15676600	Enhancers	Primary hematopoietic stem cells	blood
11	chr6:15674800-15676600	Enhancers	Brain Anterior Caudate	brain
12	chr6:15674800-15676800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr6:15675000-15675800	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr6:15675000-15675800	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr6:15675000-15675800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr6:15675000-15675800	Enhancers	K562	blood
17	chr6:15675000-15676000	Enhancers	HUES64 Cell Line	embryonic stem cell
18	chr6:15675000-15676000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr6:15675000-15676200	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr6:15675000-15676200	Enhancers	Brain Substantia Nigra	brain
21	chr6:15675000-15676400	Bivalent Enhancer	HepG2	liver
22	chr6:15675000-15676400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
23	chr6:15675000-15676600	Enhancers	Fetal Intestine Small	intestine
24	chr6:15675000-15676600	Enhancers	Sigmoid Colon	Sigmoid Colon
25	chr6:15675200-15676000	Enhancers	H1 Cell Line	embryonic stem cell
26	chr6:15675200-15676000	Enhancers	Right Atrium	heart
27	chr6:15675200-15676600	Enhancers	Brain Hippocampus Middle	brain
28	chr6:15675200-15676600	Enhancers	Duodenum Mucosa	Duodenum
29	chr6:15675200-15676600	Enhancers	Rectal Mucosa Donor 31	rectum
30	chr6:15675200-15676600	Enhancers	Skeletal Muscle Male	skeletal muscle
31	chr6:15675200-15676600	Enhancers	Spleen	Spleen
32	chr6:15675400-15675800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
33	chr6:15675400-15675800	Enhancers	Small Intestine	intestine
34	chr6:15675400-15676000	Enhancers	Fetal Stomach	stomach
35	chr6:15675400-15676400	Enhancers	H9 Cell Line	embryonic stem cell
36	chr6:15675400-15676400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr6:15675400-15676600	Enhancers	Brain Cingulate Gyrus	brain
38	chr6:15675400-15676600	Enhancers	Fetal Intestine Large	intestine
39	chr6:15675600-15676400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr6:15675600-15676400	Enhancers	Colonic Mucosa	Colon
41	chr6:15675600-15676600	Enhancers	Adipose Nuclei	Adipose
42	chr6:15675600-15676600	Enhancers	Skeletal Muscle Female	skeletal muscle
43	chr6:15675600-15676800	Enhancers	Brain Angular Gyrus	brain
44	chr6:15675800-15678200	Weak transcription	K562	blood
45	chr6:15675800-15678600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
46	chr6:15675800-15685000	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr6:15675800-15685000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
48	chr6:15676200-15676600	Enhancers	Brain Inferior Temporal Lobe	brain
49	chr6:15676200-15676600	Flanking Active TSS	Brain Substantia Nigra	brain
50	chr6:15676400-15676800	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links